Clinical Study

VocaVibe is leading a revolution in the management of neurological diseases, particularly for patients diagnosed with Parkinson’s disease. Appling artificial intelligence to analyze vocal biomarkers in a non-invasive way, without requiring any effort from the patient. Our innovative platform addresses a critical need in the current healthcare system, where diagnosis and monitoring are often delayed, based on subjective assessments, and sometimes inaccurate. Additionally, VocaVibe’s platform provides clinical and other insights to all stakeholders involved in managing the neurological disease — patients, caregivers, family members, and doctors — empowering them to take immediate and often life-saving actions that significantly improve disease management.

VocaVibe is led by a team of world-class clinical experts, including Prof. Tanya Gurevich, Head of the Movement Disorders Unit at Ichilov Hospital, Dr. Yael Manor, a global expert in speech therapy, and Prof. Sharon Hassin, Head of the Movement Disorders Unit at Sheba Medical Center.

We have launched a unique prospective clinical study in collaboration with the Movement Disorders Units at Ichilov and Sheba hospitals, which treat one-third of Parkinson’s patients in Israel. The study, involving hundreds of participants, takes place at the patients’ homes and includes meetings with caregivers and the use of an advanced app for data collection and analysis.

Who can participate in the study?

Anyone with a smartphone who can make recordings in English or Hebrew is eligible to participate, regardless of their medical condition or location including healthy people.

 Participation in the study involves:

  1. Parkinson’s patients: One self – recording per month + 3 home visits (once every 6 months) for further clinical assessment (Trial duration: over 18 months).
  2. Participants diagnosed with a sleep disorder named – REM Behaviour Disorder (RBD) or a participant with a known genetic predisposition to Parkinson’s, or a participant with a diagnosed parent: One recording every six months.
  3. Participants with no neurological disease or genetic predisposition: A one-time recording.

Each recording takes about 7 minutes.

To join the study, please fill out your details in the attached link: https://forms.gle/7YpFFpaiB1jUTSPy5
For any further questions, you can email us at info@vocavibe.ai, and we will get back to you as soon as possible.

Thank you,

The VocaVibe team

Contact Us

Skip to content